Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof

A composition and medicine technology, applied in the field of pharmaceutical compositions with uric acid-lowering effect and preparation thereof, can solve the problems of high cost of raw materials, complicated composition of raw materials, etc., and achieve the effects of simple composition, low cost and significant effect

Inactive Publication Date: 2018-03-06
CATCH BIO SCI & TECH
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned composition has disadvantages such as complex raw material composition and high raw material cost, which limit its application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] The raw materials of the pharmaceutical composition in this embodiment consist of: 32g of tea polyphenols, 22g of Clematis clematis extract, 25g of herb extract, 16g of mulberry leaf extract, and 5g of Alisma extract;

[0051] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of tea polyphenols, Clematis clematis extracts, herb extracts, mulberry leaf extracts and Alisma alisma extracts respectively, grinding and mixing uniformly to obtain the product.

[0052] The pharmaceutical composition of this embodiment is prepared into tablets by adding conventional excipients and following conventional techniques.

Embodiment 2

[0054] The raw materials of the pharmaceutical composition in this embodiment consist of: 41g of tea polyphenols, 30g of Clematis clematis extract, 16g of herb extract, 10g of mulberry leaf extract, and 3g of Alisma extract;

[0055] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of tea polyphenols, Clematis clematis extracts, herb extracts, mulberry leaf extracts and Alisma alisma extracts respectively, grinding and mixing uniformly to obtain the product.

[0056] The pharmaceutical composition of this embodiment is prepared into capsules by adding conventional excipients and following conventional techniques.

Embodiment 3

[0058] The raw materials of the pharmaceutical composition in this example consist of: 57g of tea polyphenols, 11g of Clematis clematis extract, 13g of Atractylodes atractylodis extract, 3g of mulberry leaf extract, and 16g of Alisma extract;

[0059] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of tea polyphenols, Clematis clematis extracts, herb extracts, mulberry leaf extracts and Alisma alisma extracts respectively, grinding and mixing uniformly to obtain the product.

[0060] The pharmaceutical composition of this embodiment is prepared into an oral liquid by adding conventional excipients and following a conventional process.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, healthcare products or food and particularly relates to a medicine composition with an effect of reducing uric acid as well as a preparation method andpurpose thereof. The medicine composition comprises the following raw material medicines in parts by weight: 3-78 parts of tea polyphenol, 1-38 parts of a radix clematidis extract, 1-30 parts of an atractylodes rhizome extract, 1-28 parts of a mulberry leaf extract and 1-26 parts of a rhizoma alismatis extract. The medicine composition with the effect of reducing the uric acid as well as the preparation method and the purpose thereof provided by the invention have the beneficial effects that the composition of the raw material medicines and the ratio among all the raw material medicines are fully considered, so that all the raw material medicines cooperate and interact with one another under a certain ratio, therefore, the effect of reducing the uric acid is realized; the medicine composition not only has the significant effect of reducing the uric acid, but also is less in toxic and side effects and higher in safety; the medicine composition only contains five raw material medicinesand is simple in composition and lower in cost.

Description

technical field [0001] The invention belongs to the field of medicines, health care products or food, and in particular relates to a pharmaceutical composition with the effect of lowering uric acid, a preparation method and application thereof. Background technique [0002] Gout is a crystal-associated arthropathy caused by the deposition of monosodium urate (MSU), which is directly related to hyperuricemia caused by purine metabolic disorders and / or decreased uric acid excretion. The main clinical manifestation is hyperuricemia , Gouty acute arthritis recurrent attacks, gouty chronic arthritis and tophi, gouty nephropathy and renal uric acid stones, etc. Gout specifically refers to acute characteristic arthritis and chronic tophi diseases, mainly including acute onset arthritis, tophi formation, tophi chronic arthritis, urate nephropathy and uric acid urolithiasis, and joint disability may occur in severe cases and renal insufficiency; in addition, gout is often accompanie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/884A61P19/06A23L33/105A61K31/353
CPCA23V2002/00A61K31/353A61K36/284A61K36/605A61K36/716A61K36/82A61K36/884A61K2300/00A23V2250/21A23V2200/30
Inventor 温尧林
Owner CATCH BIO SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com